The PI3K/PTEN/Akt signal transduction pathway plays a key role in many tumors. Downstream targets of this pathway include the Forkhead family of transcription factors (FOXO1a, FOXO3a, FOXO4). In PTEN null cells, FOXO1a is inactivated by PI3K-dependent phosphorylation and mislocalization to the cytoplasm, yet still undergoes nucleocytoplasmic shuttling. Since forcible localization of FOXO1a to the nucleus can reverse tumorigenicity of PTEN null cells, a high-content, chemical genetic screen for inhibitors of FOXO1a nuclear export was performed. The compounds detected in the primary screen were retested in secondary assays, and structure-function relationships were identified. Novel general export inhibitors were found that react with CRM1 as well as a number of compounds that inhibit PI3K/Akt signaling, among which are included multiple antagonists of calmodulin signaling.
Introduction
del Peso et al., 1999; Kops et al., 1999; Takaishi et al., 1999; Tang et al., 1999) . These transcription The PTEN lipid phosphatase acts as a tumor suppressor and factors are involved in negatively regulating cell cycle progresnegative regulator of PI3K/Akt-driven cell growth and survival. sion and cell survival (Medema et al., 2000; Nakamura et al., It antagonizes PI3K signal transduction by dephosphorylating 2000) . The phosphorylation state and subsequent subcellular the PI3K phosphorylation products, PI3,4,P 2 (PIP2) and PI3, localization help regulate the activity of these factors. In PTEN 4,5,P 3 (PIP3) (Maehama and Dixon, 1998) . Mutations in PTEN mutant cells, increased PIP3 levels result in constitutive activahave been implicated in Cowden Disease-a hereditary disease tion of Akt, which phosphorylates FOXO transcription factors at marked by a high predisposition for breast and thyroid cancers multiple sites, preventing transcriptional activity and promoting . In addition, PTEN deficiency has nuclear export (Biggs et al., 1999; Brownawell et al., 2001 ; Brubeen found in cancers such as glioblastoma multiforme, endonet et al., 1999; . In addition to Akt, there is metrial and prostate cancer, melanoma, and renal cell carcigrowing evidence that other kinases such as SGK, DYRK1A, noma (Kondo et al., 2001; Kong et al., 1997; Wang et al., 1997) .
CK1, and PAK1 are involved in FOXO phosphorylation and exInhibition of the PI3K/Akt signaling pathway in PTEN null cells port (Brunet et al., 2001; Mazumdar and Kumar, 2003; Rena et can control aberrant cell growth. al., 2002; Woods et al., 2001) . Phosphorylation of the FOXO Mammalian members of the FOXO or Forkhead family of transcription factors facilitates binding with 14-3-3 proteins and transcription factors include FOXO1a, FOXO3a, and FOXO4 export out of the nucleus (Brunet et al., 2002; Rena et al., 2001) . (also known as FKHR, FKHRL1, and AFX, repectively), each of which are phosphorylation targets of Akt (Brunet et al., 1999;  Nuclear export of these factors is mediated by the export recep-tor CRM1 (Biggs et al., 1999; Brownawell et al., 2001 ; Brunet ment with the nuclear export inhibitor, LMB, also resulted in FOXO1a nuclear sequestration ( Figure 1B ). As a negative conet al., 2002) .
trol, DMSO did not affect FOXO1a subcellular localization (FigMany proteins that exit the nucleus contain short stretches ure 1B). These data indicate that FOXO1a shuttles between of amino acids that act as nuclear export sequences (NESs) the nucleus and cytoplasm in a PI3K-and CRM1-dependent (Gerace, 1995) . The NES-bearing protein is bound in the nucleus manner and that the intracellular shuttling of FOXO1a is an by the nuclear export receptor, CRM1, and escorted to the appropriate measure of both PI3K/Akt pathway activation and cytoplasm via a channel formed by the nuclear pore complex CRM1 or possibly other nuclear export factor activation (Fig-(NPC) (Fornerod et al., 1997; Fukuda et al., 1997; Ossarehure 1C) . Nazari et al., 1997; Stade et al., 1997) . Leptomycin B (LMB) Using localization of FOXO1a as a visual assay, Ͼ18,000 inhibits protein nuclear export mediated by CRM1 (Kudo et al., compounds from the NCI Structural Diversity Set, ChemBridge 1998) . Isolated from Streptomyces, LMB covalently modifies DiverSetE, and a small collection of NCI marine extracts were CRM1 at a specific cysteine residue by a Michael-type addition tested for their ability to relocalize FOXO1a to the nucleus in which inhibits binding of CRM1 with the NES-containing cargo PTEN null cells. Ad-FKHR-infected 786-O cells were grown on (Kudo et al., 1999) . Thus, the NES-containing cargo becomes 384-well, clear-bottom plates before library compounds were trapped in the nucleus. FOXO transcription factors are among transferred onto cells by a 384-pin array robot. Cells were fixed those proteins whose nuclear export is inhibited by LMB (Biggs and stained after 1 hr treatment and FOXO1a localization deteret al., 1999; Brownawell et al., 2001; Brunet et al., 2002) . mined by automated fluorescence microscopy. Eighty-nine When the three known Akt phosphorylation sites on FOXO1a compounds relocalized FOXO1a to the nucleus in this primary are mutated to alanine, this AAA mutant can no longer undergo screen. Based on availability and potency, 42 total compounds phosphorylation and accumulates in the nucleus, allowing rewere obtained for further characterization (seven from the NCI constitution of FOXO1a activity to PTEN null cells (Nakamura Structural Diversity Set, 34 from ChemBridge DiverSetE, and et al., 2000; Ramaswamy et al., 1999) . Such reconstitution arone from the NCI marine extracts). rests cells in G1, inhibits soft-agar growth, and inhibits xenograft growth in nude mice, thus recapitulating many aspects of Identification of general export inhibitors PTEN-mediated tumor suppression (Nakamura et al., 2000; Ra- In order to distinguish compounds that might target the general maswamy et al., 1999). Small molecules that block FOXO1a nuclear export machinery from those that target components export could target members of the general protein transport of the PI3K/Akt/FOXO1a signaling pathway, each of the 42 small machinery and inhibit proteins other than CRM1. In addition, molecules identified in the primary screen was tested for the small molecules may act as novel kinase inhibitors, revealing ability to block the export of HIV Rev, a protein known to undergo new aspects of FOXO1a signal transduction, and serve as pre-CRM1-dependent nucleocytoplasmic transport (Wolff et al., liminary anticancer therapeutics. 1997). Here, compounds were serially diluted from 40 M and The present study describes a cell-based, chemical genetic added to U2OS cells stably expressing a RevGFP fusion protein screen using FOXO1a subcellular localization as the readout.
containing the NES from PKI. As previously shown, this RevGFP fusion localizes to the cytoplasm at steady state ( Figure 2A ) Two classes of compounds that inhibit FOXO1a nuclear export (Henderson and Eleftheriou, 2000) , and treatment of these cells were identified: (1) compounds that target the general nuclear with LMB leads to accumulation of RevGFP in the nucleolus transport machinery and (2) compounds specific to the PI3K/ ( Figure 2A) . Similarly, 19 of the initial 42 compounds blocked Akt/FOXO1a signaling pathway. Several compounds in the first RevGFP export and are thus described hereforeward as "genclass possess electrophilic moieties that most likely alkylate eral export inhibitors" ( Figure 2B ). Cys528 in CRM1 by a manner similar to the mode of action of LMB. Compounds in the second class have been characterized
The general export inhibitors target Cys528 of CRM1 further and implicate calmodulin as a mediator of FOXO1a LMB blocks NES-mediated nuclear export by covalently modinucleocytoplasmic localization and regulation.
fying CRM1 at Cys528 in humans and Cys529 in S. pombe by a Michael-type addition as illustrated in Figure 3A (Kudo et al., Results 1999 . To determine whether any of these novel general export inhibitors similarly target the CRM1 Cys528 residue, A cell-based screen for FOXO1a nuclear U2OS-RevGFP cells were transfected with a dominant-negative localization in PTEN null cells CRM1 mutant expressing a Cys528Ser substitution. Cells exIn order to identify novel nuclear transport inhibitors as well pressing this mutant are viable and insensitive to LMB-mediated as small molecules that target the PI3K/Akt/FOXO1a signaling inhibition of nuclear export (Akakura et al., 2001 ) ( Figure 3B ). pathway, a visual cell-based assay was developed that used Furthermore, cells are still sensitive to LMB when overexpressFOXO1a subcellular localization as the output. PTEN null, 786-O ing wild-type CRM1 (Akakura et al., 2001) . Of the 19 general renal carcinoma cells were infected with an adenovirus expressing export inhibitors, 11 were inactive in CRM1-Cys528Ser trans-FLAG epitope tagged FOXO1a (Ad-FKHR). Cells were grown fected U2OS-RevGFP cells, suggesting that these compounds for 24 hr after infection to allow for adequate expression of likely act by covalently modifying CRM1 at its reactive cysteine FLAG-FKHR and then treated with compounds for 1 hr, followed residue ( Figure 3C ). Approximately 50% of total cells exhibited by immunostaining and imaging. In these cells, as previously cytoplasmic RevGFP-reflective of the transfection efficiency-in published, FOXO1a is constitutively localized to the cytoplasm contrast to 100% nucleolar RevGFP in nontransfected cells. As ( Figure 1A ). In contrast, FOXO1a localizes to both the nucleus a control, cells were also transfected with wild-type CRM1 and and cytoplasm in PTEN ϩ/ϩ growing U2OS cells ( Figure 1A) . treated with the general export inhibitors. In these cells, the Treatment of infected cells with the PI3K inhibitor, wortmannin, compounds blocked RevGFP export as they did in cells not overexpressing CRM1, as previously exhibited with LMB (data led to FOXO1a relocalization to the nucleus and, likewise, treat- C: Hyperphosphorylation of FOXO1a, as a result of PI3K/Akt signal transduction, promotes FOXO1a export into the cytoplasm. Inhibition of any one of the steps in the PI3K/Akt signaling pathway, as well as members of the nuclear export machinery, can lead to FOXO1a nuclear retention. PI3K phosphorylates PI4P or PI4,5P 2 and this reaction is reversed by the lipid phosphatase, PTEN. Upon PI3,4,5P 3 formation, Akt is recruited to the membrane and can undergo phosphorylation and activation by PDK1. FOXO1a is phosphorylated by an activated Akt, as well as other kinases, leading to binding with 14-3-3 and the promotion of nuclear export by CRM1. not shown). The results for the remaining eight compounds were cells containing the mutated CRM1 were transformed with a reporter plasmid expressing GFP containing both an NLS and inconclusive in this assay. Thus, a second assay was developed in yeast to address the mode of action of these small molecules.
an NES (Taura et al., 1998) . In wild-type yeast cells, this protein shuttles between the nucleus and the cytoplasm, yet appears S. cerevisiae are insensitive to LMB because the yeast CRM1 contains a threonine at the homologous cysteine position (Nevmostly in the yeast cytoplasm ( Figure 3D ). Wild-type yeast cells transformed with the NLS-NES-GFP reporter do not show accuille and Rosbash, 1999). Cells can be made LMB sensitive by integration of a CRM1 mutant containing a Thr539Cys substitumulation of NLS-NES-GFP in the nucleus after treatment with LMB ( Figure 3D ). Conversely, in yeast cells expressing the tion in place of the wild-type yeast CRM1 (Neville and Rosbash, 1999) . Based on these observations, wild-type yeast cells and CRM1 Thr539Cys mutation, shuttling of NLS-NES-GFP is blocked upon treatment with LMB. (Figure 3D ). The 19 general black). Thus all of the general export inhibitors exhibit properties that likely explain the dependency of export inhibition on the export inhibitors, when retested in this assay, each blocked shuttling of NLS-NES-GFP in the humanized yeast. Thus, all CRM1 Cys528 residue. appear to act through the CRM1 Cys528 residue ( Figure 3E ).
Pathway-specific FOXO1a export inhibitors Twenty-three compounds, though inhibitors of FOXO1a export, Compound structures reveal their mode of action Comparing the structures of the 19 general export inhibitors to failed to alter export of RevGFP, and thus are termed pathwayor FOXO1a-specific. To determine whether such compounds the structure of LMB revealed, in eight compounds, an ␣,␤-unsaturated ketone or amide group that can likely undergo a Michaelwere likely to act upstream or downstream of Akt, extracts were prepared from 786-O cells after treatment with each of the type addition with the sulfhydryl group on Cys528 ( Figure 4A ; red). In addition, other compounds might undergo nucleophilic pathway-specific inhibitors or wortmannin, and phospho-Ser473-Akt was detected by immunoblotting. Two inhibitors (5219657 attack by the sulfhydryl group through a good halide leaving group ( Figure 4A ; blue), or across a triple bond ( Figure 4A ;
and B6-7-1) did not abolish phospho-Ser473-Akt levels similar to DMSO and thus likely have targets downstream of Akt or in green), or might undergo rearrangement for further reactivity ( Figure 4A ; pink). For three compounds, an obvious mechanism a separate synergistic pathway ( Figures 5A and 6 ). However, 21 compounds inhibited Ser473-Akt phosphorylation with varying was not apparent though each was electrophilic ( Figure 4A ; efficacy. Phospho-Thr308 Akt was also probed and all comAkt nuclear localization was investigated in 786-O cells treated with pathway-specific inhibitors. If FOXO1a is phosphorpounds that blocked Ser473 phosphorylation similarly blocked Thr308 phosphorylation ( Figures 5A and 6) . As a control, treatylated by Akt in the nucleus, then it is possible that any compounds decreasing Akt phosphorylation levels and trapping ment of cells with the general export inhibitors did not substantially alter Akt phosphorylation when tested at 20 M, though FOXO1a in the nucleus might also result in the inhibition of FOXO1a phosphorylation by Akt mislocalization. Interestingly, three exhibited modest inhibition at 40 M (Figure 6 and data not shown). Phospho-Ser255/Thr256 SGK levels were also probed treatment with the pathway-specific inhibitors did not affect Akt nuclear localization and overexpressed Akt as well as endogerevealing two compounds that significantly inhibited SGK phosphorylation ( Figure 6 ). The two compounds that showed an nous Akt was found throughout the cell (data not shown).
The pathway-specific compounds were next validated in a effect, 5175309 and 5217339, might either exhibit less specificity or perhaps affect a parallel pathway leading to SGK and second assay in which FOXO1a localization is constitutively cytoplasmic based on expression of activated PI3K. Here, huFOXO1a phosphorylation. A: General export inhibitors can covalently modify CRM1 like LMB either through an ␣,␤-unsaturated ketone or amide as shown by compounds highlighted in red. Another method might be through the substitution of a good leaving group as shown by compounds highlighted in blue. Green highlighted compounds contain a triple bond, which may undergo nucleophilic addition. Compounds in pink might undergo rearrangement for further reactivity. B: Structures of PI3K/Akt/FOXO1a specific inhibitors. Compounds in red belong to the structural family of phenothiazines. Several compounds contain planar heterocyles and may target the ATP binding sites of kinases. B6-7-1, in pink, was isolated from marine sponge extract.
man mammary epithelial cells (HMECs) containing either vector pounds have targets upstream of PI3K ( Figures 5B and 6 ). Wortmannin and twelve pathway-specific inhibitors sequestered alone or stably expressing a membrane-targeted and, hence, constitutively active p110␣ subunit of PI3K FOXO1a in the nucleus in both the vector and HMEC-Myr-p110␣ cells and thus likely act downstream of PI3K ( Figures 5B and 6 ). (Zhao et al., 2003) were infected with Ad-FKHR. FOXO1a localization was then determined by immunofluorescence after treatIn order to determine whether structure-activity relationships existed with respect to these defined phenotypes, the ment for 1 hr with each pathway-specific compound. In both cell types, FOXO1a is cytoplasmic. Thus the vector cells serve structures of all pathway-specific inhibitors were examined. Several of these compounds contain planar heterocycles that as a positive control for inhibition by a compound at any point along the PI3K pathway as well as a positive control for cellmight target the ATP binding sites of kinases. Examples include benzimidazoles (5217490, 5233705), an indole (5107360), a carspecific drug metabolic properties such as cell permeability. Nine compounds that scored repeatedly in 786-O cells failed bazole (5236848), hexahydrocarbazoles (5137877, 5271325), a quinazoline (5175309), a dihydrophenanthroline (5213337), a to score in the vector control cells, and thus their position in the pathway with respect to PI3K could not be formally estabbenzoxazole (5107769), benzofurans (5219657, 5160096), and a dibenzofuran (89110Q) ( Figure 4B ). B6-7-1, from a marine lished in this assay ( Figures 5B and 6 ). Two compounds (89110Q, 293046M) blocked FOXO1a export in control cells, sponge extract, is an amino acid derived, novel bromotyrosine derivative ( Figure 4B ; pink). but not in HMEC-Myr-p110␣ cells, suggesting that these com- 
Phenothiazines-a class within
the broader class of phenothiazines, additional phenothiazines including chlorpromazine, prochlorperazine, fluphenazine, and the pathway-specific inhibitors Of particular interest was the finding that three of the pathwaythioridazine were tested in the FOXO1a export assay. All of these compounds blocked FOXO1a export in 786-O cells ( Figure 7A ), specific inhibitors belonged to the structural family of phenothiazines ( Figure 4B ; red) (17474Z, 186057T, 5216177), one of raising the possibility that FOXO1a nuclear localization might be regulated by dopamine receptor signaling. Indeed, phosphowhich was trifluoperazine (17474Z). Trifluoperazine, as well as many other phenothiazines, act as dopamine receptor antagoAkt levels increase when cells are treated with dopamine receptor agonists such as quinpirole and bromocriptine in neuronal nists and are clinically useful as antipsychotic and antiemetic medications. Like wortmannin, the three phenothiazines relocalcells (Brami-Cherrier et al., 2002; Kihara et al., 2002) . To investigate whether inhibiting the dopamine receptor can ized FOXO1a in 786-O cells to the nucleus, decreased phosphoAkt levels ( Figure 5A ), and in two instances blocked export in lead to FOXO1a nuclear retention, structurally unrelated dopamine receptor antagonists were tested in the FOXO1a export HMEC Myr-p110␣ cells (Figures 5B and 6) .
To determine whether these activities were representative of assay. None of the inhibitors-haloperidol, clozapine, L745870, Compound numbers beginning with "5" are the ID numbers from ChemBridge and those beginning with "NSC" are the ID numbers from the NCI. Dark gray denotes the compound scored in the assay (e.g., blocks FOXO1a or RevGFP export; inhibits CRM1 in U2OS-RevGFP transfected cells or in the yeast NLS-NES-GFP export assay; decreases phospho-protein levels; blocks cell proliferation). Light gray denotes the compound has weak activity in the assay and white denotes the compound showed no activity in the assay. Black denotes the compound was not tested in the assay.
or L-stepholidine (L-SPD)-significantly blocked FOXO1a expounds in cells (Mottet et al., 2003; Wei et al., 1983; Yang et al., 2000) . Treatment with the Ca 2ϩ chelator, BAPTA-AM, also port at concentrations comparable to those previously used to block dopamine receptors in cells (Dong et al., 1997; Patel et blocked FOXO1a nuclear export at 80 M ( Figure 7C ). However, treatment with EGTA, an extracellular calcium chelator, did not al., 1997; Vanhauwe et al., 2000) (Figure 7B ). These data strongly suggest that the dopamine receptor is not the relevant target result in FOXO1a nuclear localization (data not shown). These data are consistent with the notion that CaM activity regulated of the phenothiazines with respect to their activity as inhibitors of FOXO1a export.
by intracellular Ca 2ϩ regulates FOXO1a subcellular localization.
786-O cell proliferation in presence of compounds Structurally unrelated CaM inhibitors block FOXO1a export
IC50s were determined for all 42 lead compounds in cell proliferation studies. In these studies, 786-O cells were grown in 96-Trifluoperazine (17474Z), in addition to its dopamine receptor antagonist activity, also exhibits inhibitory activity against calwell plates and treated for ‫42ف‬ hr at decreasing concentrations of inhibitor serially diluted in complete media from 40 M to 1.25 modulin Weiss, 1976, 1977) , raising the possibility that it and the phenothiazine class as a whole might interrupt M. Cell viability was determined by correlation with amount of ATP released when cells were lysed. The results for these PI3K signaling through calmodulin inhibition. To ask whether this was the case, Ad-FKHR infected 786-O cells were treated experiments are reported in Figure 6 , which also summarizes the results of the assays for all general export and pathwayfor 1 hr with the calmodulin inhibitors W-13, calmidazolium, and ophiobolin A. Each of these inhibitors relocalized FOXO1a to the specific inhibitors. Most of the inhibitors block cell proliferation; however, ten compounds exhibited no effect at 40 M, including nucleus ( Figure 7C ). Moreover, when tested in serial titrations, FOXO1a export was blocked at concentrations comparable to wortmannin. It is possible these compounds, as with wortmannin, are unstable in aqueous solution for an extended period of those previously reported for CaM inhibition by these com- time (Stein and Waterfield, 2000; Woscholski et al., 1994) . Thus, by the discovery of small molecules specifically targeting key compounds that localize FOXO1a to the nucleus after 1 hr may cellular proteins, and as such, 19 novel CRM1 export inhibitors not inhibit proliferation in this 24 hr assay.
were identified. Furthermore, a calmodulin-dependent regulatory mechanism for controlling FOXO1a localization was discovered. These data suggest that such screens, when conducted Discussion in defined systems, can be highly informative and likely compliment traditional in vitro target-based drug screens. A cell-based, visual, chemical genetic screen for small molecule inhibitors of nuclear export of the transcription factor FOXO1a
We have shown that 19 of the compounds that promote retention of FOXO1a in the nucleus are novel general protein was carried out in cancer-derived cells lacking functional PTEN protein. The utility of this "phenotypic" screen was validated export inhibitors. All 19 block the nuclear export of RevGFP and FOXO1a by targeting CRM1, and not by inhibition of other FOXO1a signaling pathway were identified. Among these were factors in the nuclear transport machinery. Interestingly, all of a novel natural product from marine sponge and several comthese general inhibitors were isolated from the ChemBridge pounds containing planar aromatic heterocycles similar to the DiverSetE and make up about half of the total hits from that scaffolds of known kinase inhibitors. These latter compounds library. While most, if not all, of the general blockers are reactive, may potentially inhibit the activity of kinases involved in Akt not all of the reactive compounds in the library relocalized signaling or FOXO1a phosphorylation and export. Experiments FOXO1a in this screen, suggesting that the compounds identidesigned to localize the inhibitory activity of these compounds fied in the screen exhibit some selectivity for CRM1. Of the 19 within the pathway are ongoing. compounds in this class, 5219668 is the most potent CRM1
Three of the pathway-specific compounds belong to the inhibitor (Figure 6 ). While not as potent as LMB, in some cases structural family of phenothiazines, including trifluoperazine, a this compound can make a suitable substitute when inhibition known dopamine receptor antagonist and CaM inhibitor. While of general export is required in experiments.
trifluoperazine and several other phenothiazine dopamine reSurprisingly, targeting of CRM1 by the general export inhibiceptor antagonists relocalized FOXO1a to the nucleus, structors invariably required the Cys528 residue and the chemical turally unrelated antagonists such as haloperidol, clozapine, structures suggest that this dependency likely results from cova-L745280, and L-SPD did not. Trifluoperazine and other phenolent interactions. On the other hand, the Cys528 residue is not thiazines such as fluphenazine and chlorpromazine also inhibit required for CRM1 function and the three-dimensional structure CaM in addition to dopamine receptors. Additional structurally of CRM1 has not been determined. Therefore, the specific diverse calmodulin inhibitors such as W-13, calmidazolium, and mechanism by which covalent attack on this residue leads to ophiobolin A robustly relocalized FOXO1a to the nucleus. Furinhibition is not known. The diversity of this new expanded set thermore, treatment of 786-O cells with the intracellular Ca 2ϩ of CRM1 inhibitors may shed light on this question. Specifically, chelator, BAPTA-AM, likewise relocalized FOXO1a to the nuwhile it appears that Cys528 binding is required, it may not be cleus, strongly suggesting that calmodulin is a regulator of sufficient. Thus, determining the structure-activity requirements FOXO1a cellular location. Interestingly, the natural marine of the reactive compounds scoring in this assay may define any sponge product, B6-7-1, is a bromotyrosine and resembles the additional requirements.
bastadins. Bastadins have been shown to modulate ryanodine Although S. cerevisiae express a form of CRM1 that does receptors, Ca 2ϩ release channels in the sarcoplasmic reticulum not contain the reactive cysteine residue, S. pombe, human, and (Mack et al., 1994) . Though untested, it is possible that B6-7-1 most other organisms do. The subselection of specific reactive might block Ca 2ϩ channels and thereby reduce the intracellular compounds interacting with CRM1 begs the question of whether Ca 2ϩ concentration. Such an effect, as mimicked by our experithe export receptor CRM1 can act as a general sensor for certain ment with BAPTA-AM, might prevent Ca 2ϩ from binding to CaM, types of reactive compounds in nature. For example, cellular inactivate CaM, and therefore keep FOXO1a nuclear. and transcriptional responses to small molecule toxins present Reducing intracellular Ca 2ϩ levels or inhibiting CaM leads in the environment might be mediated through CRM1 binding to inactivation of Akt in PC12 cells (Egea et al., 2001) . Similarly, and inactivation. Such inactivation would render CRM1 unable BDNF activation of Akt is blocked in cells expressing CaM with to export NES-containing proteins and certain transcription facmutant Ca 2ϩ binding domains . The calmodutors, including FOXO proteins. Trapped in the nucleus, these lin inhibitor, W-13, while unable to alter PI3K or Akt kinase proteins might then enact transcriptional programs resulting in activity in vitro, decreases phospho-Akt levels in adipocytes in a cell cycle arrest or apoptosis, as examples. In this light, CRM1 a PI3K-independent manner (Egea et al., 2001 ; Yang et al., might act as a protector of the cell. 2000) . Together, these suggest the presence of a CaM-depenThe utility of LMB as a therapeutic has been explored with dent, PI3K-independent path to Akt activation. Finally, Ca 2ϩ / respect to the role of CRM1 in regulating p53 localization. For calmodulin-dependent protein kinase kinase (CaM-KK) can example, trapping p53 in the nucleus with LMB results in its phosphorylate Akt and SGK1 through a Ca 2ϩ /CaM signaling reactivation and transduction of its biological responses includpathway (Imai et al., 2003; Yano et al., 1998) . Thus, one possibiling cellular apoptosis (Hietanen et al., 2000; Lain et al., 1999a) , ity is that FOXO1a cellular localization and activity might be leading some to propose targeting nuclear transport as a means regulated by a Ca 2ϩ /CaM signaling cascade that results in the of controlling cancer growth (Kau and Silver, 2003; activation of CaM-KK and phosphorylation of both Akt and 1999b). In phase I clinical trials, however, targeting CRM1 with SGK1 by CaM-KK. LMB was associated with profound toxicity (Newlands et al.,
A schematic of the pathway depicting the site of action for 1996). Cells expressing mutant CRM1 are resistant to LMB; the compounds that we have characterized thus far is shown thus, it is critical to understand whether patient-related toxicity in Figure 8 . Several of the compounds might prove to be leads is target related or due to non-CRM1, off-target effects of LMB.
for potential anticancer drug development including trifluoperIf patient-related toxicity is linked to non-CRM1 effects of LMB, azine and 5233705. There is an ongoing vigorous debate on the then the possible lower toxicity of some of the compounds virtues or perils of cell-based screening. This particular screen identified in this screen could potentially guide the preclinical proved robust, facile, highly amenable to academic scale development of CRM1 inhibitors with improved therapeutic screens, and more importantly, elucidated previously undiscovindex. ered export and PI3K pathway inhibitors. Furthermore, we have One of the inherent strengths of our FOXO1a-based screen determined the specific molecular mechanism for inhibition of is the ability to identify both general export inhibitors and more representative compounds within both classes of inhibitors, specific effectors of the signaling pathways that promote leading to the discovery of novel CRM1 inhibitors and revealing FOXO1a movement and activity. Thus, 23 small molecule inhibitors of FOXO1a export that appear to act in the PI3K/Akt/ the role of CaM in regulating PI3K signaling to FOXO1a. Experi- p110␣ and HMEC-vector, were previously described in Zhao et al. (2003) .
ments are currently underway to identify the targets of the reCells were grown in mammary epithelial basal medium (MEBM, BioWhittaker) maining pathway-specific compounds.
supplemented with mammary epithelial growth medium (MEGM, BioWhittaker) consisting of hydrocortisone, EGF, insulin, and bovine pituitary extract.
Experimental procedures
Wild-type yeast PSY580 and CRM1 mutant yeast PSY1969 were transformed with the NLS-NES-GFP plasmid using a standard transformation Materials protocol. Transformants were selected on ura Ϫ dropout plates. LMB, wortmannin, and haloperidol were purchased from Sigma. L-SPD, W-13, calmidazolium, and ophiobolin A were purchased from Calbiochem.
Adenovirus construction BAPTA-AM was purchased from Molecular Probes. L754870 was purchased Ad-FKHR was generated with the pAD-Easy system (He et al., 1998) . In from Tocris. Clozapine was purchased from Alexis Corp. Phenothiazine brief, linearized shuttle plasmid containing the cDNA for FLAG-FOXO1a was therapeutics thioridazine, fluphenazine, chlorpromazine, and prochlorperacotransfected with pAdEasy-1 into BJ5183 cells. After isolation, recombinant zine were purchased from ICN Biomedicals, Inc. adenoviral DNA was restriction digested with PacI and transfected into 293 Lead compounds from the screen were ordered from ChemBridge Corp. cells. Infectious adenovirus was amplified in 293 cells. Purified virus was or requested from the NCI. The pRev(1.4)-GFPϩPKI NES plasmid was a gift isolated by freeze-thaw extraction followed by CsCl gradient purification from Beric Henderson and its construction described in Henderson and and titred by plaque lysis. Eleftheriou (2000) . The CRM1-Cys528Ser mutant plasmid, pXHCK1, was a gift from Minoru Yoshida and previously described in Akakura et al. (2001) .
FOXO1a export assay in 786-O and HMEC cells The NLS-NES-GFP plasmid (pPS1372) was previously described in Taura 786-O cells were seeded onto 384-well, black, clear-bottom plates (Costar) et al. (1998) .
at a density of ‫0003-0052ف‬ cells/well in 50 l complete media. After incubation at 37ЊC, 5% CO 2 for 2-3 hr, cells were infected with Ad-FKHR and Cell culture and yeast strains incubated for ‫42ف‬ hr. Small molecule compounds were serially diluted 1:2 786-O and U2OS-RevGFP cells were grown and maintained in Dulbecco's starting from 80 M in a separate 384-well plate using a 16-channel pipette modified Eagle's medium (DMEM) containing 10% Fetal Clone (Clonetech) (ThermoLabsystems) in DMEM. Media were aspirated from infected cells and 100 g/ml penicillin-streptomycin at 37ЊC, 5% CO 2 . U2OS-RevGFP using a 24-channel wand before diluted small molecules were transferred cells were established by transfecting U2OS cells with pRev(1.4)-GFPϩPKI onto cells. Cells were incubated for ‫1ف‬ hr before 3.7% formaldehyde fixation. NES using FuGENE 6 reagent according to the manufacturer's protocol Fixed cells were then stained with M5 anti-FLAG antibody (Sigma) followed (Boehinger Mannheim). Stable clones were selected in complete media containing 400 g/ml G418. Human mammary eptithelial cells, HMEC-Myrby washing with PBS three times and staining with Alexa Fluor 594 goat anti-mouse antibody (Molecular Probes) and Hoechst 33258 (Sigma). Both concentrations were determined using Bradford reagent (Bio-Rad) and aliantibodies, M5 and Alexa Fluor 594, were diluted 1:1000 in PBS/0.2%TX-quots of lysates with equal amounts of protein were resolved by SDS-PAGE 100/5%FBS. For cell counts, at least 200 cells exhibiting nuclear, nuclear and transferred onto Immobilon-P membranes (Millipore). Membranes were and cytoplasmic, or cytoplasmic staining were counted from three separate blocked in 5% powdered milk in PBST (PBS, 0.2% Tween-20), incubated images. Percentages of N, NϩC, and C cells were calculated and standard overnight at 4ЊC in phospho-Ser473-Akt antibody (Cell Signaling) diluted deviations determined.
1:1000 in PBST containing 5% BSA. Phospho-Ser473-Akt levels were de-HMEC's were treated similarly except they were seeded at a density of tected using anti-rabbit HRP diluted 1:5000 in 5% milk/PBST followed by ‫0053ف‬ cells/well and incubated overnight before infection with Ad-FKHR Western Lightning chemiluminescence reagent (PerkinElmer). Blots were virus. Compounds were diluted in MEBM supplemented with MEGM. stripped in stripping buffer (100 mM glycine, HCl/pH 2.5), washed twice in PBST, and blocked in PBST containing 5% milk before re-probing with pan High-throughput screen Akt antibody (Cell Signaling) diluted 1:1000 in PBST/5% BSA. PhosphoCell-based screening was performed at the Institute for Chemistry and Cell SGK (Upstate) was diluted 1:200 in PBST/5%BSA. For phospho-Thr308-Biology (http://iccb.med.harvard.edu). 786-O cells were seeded onto black, Akt (Cell Signaling) immunoblots, membranes were blocked in 4% milk in clear-bottom, 384-well plates at ‫0003-0052ف‬ cells/well in 50 l complete TBST and secondary anti-rabbit HRP was diluted 1:3000 in 2% milk/TBST. media using a Multidrop liquid dispenser (Labsystems). Cells were then incubated for 3 or 17 hr before infection with Ad-FKHR for ‫42ف‬ hr. ComCell viability assay pounds from the ChemBridge DiverSetE (ChemBridge Corp.) and the NCI 786-O cells were seeded onto opaque, white, 96-well plates (Costar) at Structural Diversity Set (NCI) were kept at a stock concentration of 5 mg/ml ‫0052ف‬ cells/well density and incubated for 24 hr. Compounds were serially ‫01ف(‬ mM) in DMSO. 100 nl of each compound, as well as those from the diluted 1:2 from 40 M to 1.125 M on a different 96-well plate in serum-NCI marine extract plate, were transferred to cells by a solid 384-pin array containing media. 100 l of each dilution was transferred onto cells after device attached to a robotic arm. Cells were then incubated for ‫1ف‬ hr at removal of media. Cells were incubated with inhibitors for ‫42ف‬ hr. Cell 37ЊC, 5% CO 2 . Formaldehyde fixation and antibody staining were performed viability was assayed using CellTiter-Glo luminescent cell viablilty assay as described in the FOXO1a export assay.
(Promega) following the manufacturer's protocol. Digital images of cells in each well were acquired using an automated fluorescence microscope equipped with a Plan Fluor 10X NA 0.3 objective Acknowledgments (Nikon) and Metamorph software (Universal Imaging). FOXO1a subcellular localization was scanned visually for each imaged plate.
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Phospho-Akt and phospho-SGK immunoblot
Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular 786-O cells were grown to confluency in 6-well tissue culture plates. Cells distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol. 21, 3534-3546. were then treated with compound diluted in 2 ml DMEM at decreasing concentrations, (e.g., 40, 20, and 10 M) for ‫1ف‬ hr at 37ЊC, 5% CO 2 . Cells Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S., Anderson, were then scraped in PBS, pelleted, and lysed in extract buffer (10 mM Tris M.J., Arden, K.C., Blenis, J., and Greenberg, M.E. (1999) . Akt promotes cell [pH 7.4], 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM survival by phosphorylating and inhibiting a Forkhead transcription factor. Na 4 P 2 O 7 , 2 mM Na 3 VO 4 , 1% Triton X-100, 10% glycerol, 0.5% deoxycholate, Cell 96, 857-868. 1 mM PMSF, PLAC). Lysates were spun at 14,000 ϫ g for 10 min and supernatants aliquoted, frozen on dry ice, and stored at Ϫ80ЊC. Protein Brunet, A., Park, J., Tran, H., Hu, L.S., Hemmings, B.A., and Greenberg, M.E.
